WallStreetZenWallStreetZen

NASDAQ: NRBO
Neurobo Pharmaceuticals Inc Earnings & Revenue

NRBO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$16.6M
Current Profit Margin
0%

NRBO Return on Equity

Current Company
-90.2%
Current Industry
16.7%
Current Market
28.2%
NRBO's Return on Equity (-90.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NRBO announces earnings.

NRBO Return on Assets

Current Company
-69.5%
Current Industry
3.2%
NRBO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NRBO Return on Capital Employed

Current Company
-162.66%
Current Industry
-43.6%
NRBO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRBO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NRBO$0.00-$16.57M-$16.58MN/AN/A
LYRA$1.68M-$68.69M-$68.88M+49.37%N/A
FBRX$0.00-$32.13M-$32.14M-100.00%N/A
GDTC$0.00-$2.72M-$3.04MN/AN/A
LSTA$0.00-$23.00M-$20.05MN/AN/A

NRBO earnings dates

Next earnings date
Jun 7, 2024

Neurobo Pharmaceuticals Earnings & Revenue FAQ

What were NRBO's earnings last quarter?

On Invalid Date, Neurobo Pharmaceuticals (NASDAQ: NRBO) reported Q1 2024 earnings per share (EPS) of -$1.32, up 158.82% year over year. Total Neurobo Pharmaceuticals earnings for the quarter were -$6.71 million. In the same quarter last year, Neurobo Pharmaceuticals's earnings per share (EPS) was -$0.51.

If you're new to stock investing, here's how to buy Neurobo Pharmaceuticals stock.

What was NRBO's earnings growth in the past year?

As of Q2 2024, Neurobo Pharmaceuticals's earnings has grown year over year. Neurobo Pharmaceuticals's earnings in the past year totalled -$16.58 million.

What is NRBO's earnings date?

Neurobo Pharmaceuticals's earnings date is Invalid Date. Add NRBO to your watchlist to be reminded of NRBO's next earnings announcement.

What was NRBO's revenue last quarter?

On Invalid Date, Neurobo Pharmaceuticals (NASDAQ: NRBO) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Neurobo Pharmaceuticals's revenue was $0.00.

What was NRBO's revenue growth in the past year?

As of Q2 2024, Neurobo Pharmaceuticals's revenue has grown null year over year. Neurobo Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.